Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
about
Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilRamipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in ratsInteraction of bradykinin with angiotensin, prostacyclin, and nitric oxide in myocardial preservation.Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin IIVasopeptidase inhibition: effective blood pressure control for vascular protection.ACE inhibition and atherogenesis.Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure.Ramipril-induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor-NO pathway and protein synthesisAnti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol dietEffects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive ratsPotentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril.Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide.New fACEs to the renin-angiotensin system.Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical Therapy.The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesThe fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.Renin inhibition in the treatment of diabetic kidney disease.Cadmium attenuates bradykinin-driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase.Physiological and pathophysiological roles of nitric oxide.Hyperactive tissue renin-angiotensin systems in cardiovascular dysfunction: experimental evidence and clinical hypotheses.The role of endothelium in the pathogenesis of diabetic microangiopathy.1993 Mack Forster Award Lecture. Review. The endothelium as a target and mediator of cardiovascular disease.Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.The renin-angiotensin-aldosterone system and cardiac ischaemia.Ramiprilat increases bradykinin outflow from isolated hearts of rat.Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.ACE inhibitor potentiation of bradykinin-induced venoconstriction.Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.Peripheral circulatory adaptations to pump failure of the heart.Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.Involvement of nitric oxide in the regional haemodynamic effects of perindoprilat and captopril in hypovolaemic Brattleboro rats.Synthesis of kininogen and degradation of bradykinin by PC12 cells.Beneficial effects of therapy on the progression of structural remodeling during healing after reperfused and nonreperfused myocardial infarction: different effects on different parameters.Enalapril attenuates endothelin-1-induced hypertension via increased kinin survival.
P2860
Q28368347-88AC9CF8-56B8-4813-AB14-0C67C11F6838Q28379293-35CC5E17-ED22-4C2C-99E6-4D30EEBEE1C2Q33189033-29CE23A3-EB25-4D52-9703-66620F46BB60Q33189269-7A960F33-D818-4886-8755-CA60003D9F10Q33692456-F6B8BBA8-A25D-476E-8F54-DA10945B8824Q34023281-5D6EC3CF-8B29-40BE-8DB9-ED6E90050FD8Q34492839-BF9D8C5C-0FB5-47C8-A4C7-BA56BDECB8B9Q34652136-CDABFC27-CE84-446B-BF07-0BA49C53BAE4Q35026019-B386192B-164B-4F70-87B1-274B344968B5Q35027113-5FB41931-06C5-4B8E-A416-FE8D2B6CA4DCQ35028061-16BC4E12-3A57-4597-8A8F-E933E208E2F0Q35041595-C2CBFC43-DDF0-4246-84BF-5145090AFB4EQ35870675-56A57142-2052-4692-8771-8AB9E69FBF1EQ35874329-12034161-B900-4D37-923D-6A84E53FE8D5Q35874540-B17466FE-07E2-4AF4-A967-20E28C860E5EQ35991112-12EFDFB5-2546-4CEC-928F-29F4237FC0B4Q36072691-8829913F-23A2-476E-97D6-D421D91BD512Q36334981-5E2B8D45-3D41-4DCE-8AD5-282031C20AC7Q37158159-3B74124D-9BEA-438D-BF31-AC9666972211Q37523449-46279737-0015-4B11-A724-FAE6E7C74D27Q38075571-0CC1D911-2481-431F-AD71-028F396281AAQ39797118-14006750-8FE6-4D74-AA79-6BBEFC6C2EC8Q40398512-9999863B-4A93-40B4-9843-0A0396BC13E1Q40446000-E6B67E66-F552-4AE7-8342-5EE5C8EC1342Q40751194-9FBFE045-1503-4C7A-A130-5CE137E58159Q40814163-414854B1-F64C-46D6-BAB2-ABA2F69C41DEQ41143381-ACDA1512-D0F6-4C7D-AB03-85E8DE295629Q41292908-BBAD1142-DC3C-4EB3-A612-7E105BF70576Q41770180-3A22786C-6C19-4665-85BD-4733A30DC15CQ41811895-FC9704DE-89DB-488E-A6E1-66F6B7916960Q41894719-658A0C88-6DB6-4952-BA22-A6264AB140C6Q41915142-6F8108F6-0F9B-4BA4-8362-DD63F3225C96Q42148125-2E10970F-C20B-4B27-A322-B226921E4C1AQ42546834-ADA2F480-BC8F-438B-9D44-B9D94D467222Q42578714-3E8B3145-94AD-4714-BC9F-5C767278CC6CQ42711400-7E2FD35E-E11A-4044-A371-6F27D8C2F409Q42715463-80270779-C9B1-41D6-98BF-617DBEEBA97CQ43179446-91067C87-FAF8-46A4-8481-3255DA27467CQ44035606-13984899-1199-4171-8F87-EE83B7E5D7B5Q44306632-C2A5D0BD-36E0-45DB-9615-96EAF9065612
P2860
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
name
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@ast
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@en
type
label
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@ast
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@en
prefLabel
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@ast
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@en
P2093
P356
P1433
P1476
Ramiprilat enhances endothelia ...... ndothelium-derived bradykinin.
@en
P2093
P304
P356
10.1161/01.HYP.18.4.558
P407
P577
1991-10-01T00:00:00Z